{"disease":{"id":"pathological-complete-remission","name":"pathological complete remission"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04939103","title":"TRUS-FNA For The Prediction Of pCR After Neoadjuvant Treatment In Rectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Sixth Affiliated Hospital, Sun Yat-sen University","has_results":false},{"nct_id":"NCT07430579","title":"Adebrelimab Combined With Chemotherapy for the Esophageal Squamous Cell Carcinoma","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"The Second Hospital of Shandong University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}